Monoklonale Antikörper bei Patienten mit chronisch-entzündlicher Darmerkrankung
- 30 June 2025
- journal article
- klinische studien
- Published by Springer Nature in Die Innere Medizin
- p. 1-4
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studiesThe Lancet, 2024
- EFFICACY AND SAFETY OF GUSELKUMAB THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS OF THE GALAXI 2 & 3 PHASE 3 STUDIESGastroenterology, 2024
- Mirikizumab as Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2023